Application area

In the complex therapy of ischemic heart disease (after myocardial infarction), in cases of myocardiodystrophy and heart rhythm disorders caused by the use of cardiac glycosides. In the complex therapy of liver diseases (hepatitis, cirrhosis, liver steatosis). During surgery on the isolated kidney as a means of pharmacologic protection during circulatory shutdown.

Application area

Metabolic agent


Market authorization in the following countries


Back to catalog